LZB vs REAL
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
La-Z-Boy exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a conservative debt-to-equity ratio of 0.54. While the current price of $35.21 aligns closely with the Graham Number ($33.86), suggesting defensive fair value, there is a stark divergence from the growth-based intrinsic value of $14.0. The company is currently battling significant earnings contraction (-23.5% YoY) despite modest revenue growth. The outlook is a tug-of-war between a robust balance sheet and deteriorating profitability trends.
The RealReal exhibits a critical divergence between fundamental health and growth momentum. The Piotroski F-Score of 2/9 indicates severe financial weakness, compounded by a negative Price/Book ratio (-3.44) suggesting negative shareholders' equity and a Current Ratio (0.86) that signals liquidity risk. However, the company shows strong operational recovery with 18.3% YoY revenue growth and a significant positive shift in EPS trajectory. While analysts maintain a 'strong_buy' rating with a target of $18.19, the bearish insider sentiment and poor deterministic health scores necessitate a cautious approach.
Compare Another Pair
Related Comparisons
LZB vs REAL: Head-to-Head Comparison
This page compares La-Z-Boy Incorporated (LZB) and The RealReal, Inc. (REAL) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.